{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:02:21Z","timestamp":1791414141081,"version":"4.3.3"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Infect Dis."],"published-print":{"date-parts":[[2015,10,1]]},"DOI":"10.1093\/cid\/civ478","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T00:49:50Z","timestamp":1434674990000},"page":"1043-1048","source":"Crossref","is-referenced-by-count":57,"title":["A Phase 2 Trial of Oral Solithromycin 1200 mg or 1000 mg as Single-Dose Oral Therapy for Uncomplicated Gonorrhea"],"prefix":"10.1093","volume":"61","author":[{"suffix":"III","given":"Edward W.","family":"Hook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Golden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula B.","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne S.","family":"Harbison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvan","family":"Lowens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhavathi","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,6,18]]},"reference":[{"key":"2015092108454797000_61.7.1043.1","unstructured":"Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2012. Atlanta, GA: CDC, 2014. Available at: http:\/\/www.cdc.gov\/std\/stats12\/default.htm. Accessed 1 July 2015."},{"key":"2015092108454797000_61.7.1043.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.176575"},{"issue":"RR-12","key":"2015092108454797000_61.7.1043.3","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2010","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"2015092108454797000_61.7.1043.4","first-page":"590","article-title":"Update to CDC's sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2015092108454797000_61.7.1043.5","first-page":"300","article-title":"Antibiotic allergy","volume-title":"Principles and practice of infectious diseases","author":"Kuruvilla","year":"2015"},{"key":"2015092108454797000_61.7.1043.6","doi-asserted-by":"publisher","DOI":"10.1097\/01.OLQ.0000109514.91508.FC"},{"key":"2015092108454797000_61.7.1043.7","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3182685d2b"},{"key":"2015092108454797000_61.7.1043.8","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-199403000-00010"},{"key":"2015092108454797000_61.7.1043.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.09.018"},{"key":"2015092108454797000_61.7.1043.10","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00860-10"},{"key":"2015092108454797000_61.7.1043.11","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00036-12"},{"key":"2015092108454797000_61.7.1043.12","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02411-14"},{"key":"2015092108454797000_61.7.1043.13","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01343-09"},{"key":"2015092108454797000_61.7.1043.14","first-page":"100","article-title":"Performance standards for antimicrobial susceptibility testing; 23rd informational supplement. CLSI document M100-S23","volume":"33","author":"Clinical and Laboratory Standards Institute","year":"2013"},{"key":"2015092108454797000_61.7.1043.15","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq074"},{"key":"2015092108454797000_61.7.1043.16","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.10.3596-3601.2002"},{"key":"2015092108454797000_61.7.1043.17","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000102"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/61\/7\/1043\/818378\/civ478.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T20:54:08Z","timestamp":1503435248000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/civ478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,18]]},"references-count":17,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,9,5]]},"published-print":{"date-parts":[[2015,10,1]]}},"alternative-id":["10.1093\/cid\/civ478"],"URL":"https:\/\/doi.org\/10.1093\/cid\/civ478","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,18]]}}}